Rolida, Ramel D.
HRN: 04-18-56 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/31/2025
09/07/2025
IV
600MG
Q8H
CELLULTIS
Checking Initial Appropriateness
09/11/2025
CO-AMOXICLAV 625MG (TAB)
09/11/2025
09/17/2025
PO
625
TID
CEllulitis
Checking Initial Appropriateness
09/11/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
09/11/2025
09/17/2025
TOPICAL
Apply Thinly
BID
Cellulitis
Checking Initial Appropriateness
09/12/2025
CLINDAMYCIN 300MG (CAP)
09/13/2025
09/15/2025
ORAL
600mg
Q8h
Cellulitis R Foot
Checking Initial Appropriateness